IBI - Istituto Biochimico Italiano Giovanni Lorenzini S.p.a.
Francesca Rubino's work experience includes serving as an HR Director at Istituto Biochimico Italiano Giovanni Lorenzini S.p.a. and ibi lorenzini spa since 2006. Francesca was also an HR Manager at data ufficio srl from 1996 to 2000 and an Area Manager at lidl italia from 1995 to 1996. In 2020, they participated as a Judge in the Enactus World Cup 2020.
Francesca Rubino completed a Master's in Labor Law at confindustria latina from 2009 to 2010. From 2007 to 2008, they attended confindustria latina for the Alma Graduates School program (Università di Bologna) in General Management. Francesca also has a Bachelor's degree in Economics and Commerce from Universita' La Sapienza Roma, which they obtained from 1987 to 1993. Additionally, they hold certifications such as the HRC TOP HR DIRECTOR AWARD 2023 from HRC International Group and a Black Belt from the percorso certificativo aziendale con master b, obtained in 2020.
This person is not in any teams
IBI - Istituto Biochimico Italiano Giovanni Lorenzini S.p.a.
IBI (Istituto Biochimico Italiano G. Lorenzini Spa) is a leading international biopharmaceutical company that has been operating since 1918. Specializing in aseptic manufacturing of Injectable Medicinal Products, IBI has established direct commercial presence in the UK, Germany, and Italy, while also exporting through alliances to more than 20 countries worldwide, including the US, Australia, and Europe. IBI offers comprehensive CDMO services, including advanced formulation, process development, and GMP manufacturing of sterile finished products. Their expertise extends to developing solutions and freeze-dried powders for both chemical and biotech active ingredients, such as small molecules, monoclonal antibodies, recombinant proteins, oligonucleotides, and nanoparticle technologies. IBI is certified by FDA, AIFA (EU), EDQM, TGA. More information: www.ibi-lorenzini.com Business Development: bd@ibi-lorenzini.com • GMP production for biological medicinal products (active substance from CHO cell culture, peptides, monoclonal antibodies) • GMP production of sterile drug products • GMP production of sterile API and finished products • CDMO and GMP production for orals, topicals, injectables • Aseptic filling of injectable medicinal products • Micro and nanoparticles formulations aimed to delivery of different classes of active molecules • Pharmaceutical development • Analytical validations, stability testing • MA and IMP registration and Batch Release services • Investigational Medicinal Product production